Zomepirac

CHEMBL19490 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

291.7 g/mol

LogP

2.8

Phase

4

Zomepirac is a nonsteroidal anti-inflammatory drug (NSAID) and analgesic that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis to produce analgesic and anti-inflammatory effects. It was used for moderate to severe pain management but was withdrawn from the market due to serious anaphylactic reactions occurring particularly in aspirin-sensitive patients. It was notable for its potent analgesic effects comparable to opioids for some pain types.

Berat Molekul

291,7300 g/mol

LogP

2,80

TPSA

59,30 Å²

Lipinski RO5

Lulus

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1cc(CC(=O)O)n(C)c1C(=O)c1ccc(Cl)cc1

InChI

InChI=1S/C15H14ClNO3/c1-9-7-12(8-13(18)19)17(2)14(9)15(20)10-3-5-11(16)6-4-10/h3-7H,8H2,1-2H3,(H,18,19)

Molecular Formula

C15H14ClNO3

HBD / HBA

1 / 3

Ikatan yang Dapat Dirotasi

4

Atom Berat

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Zomepirac is a nonsteroidal anti-inflammatory drug (NSAID) and analgesic that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis to produce analgesic and anti-inflammatory effects. It was used for moderate to severe pain management but was withdrawn from the market due to serious anaphylactic reactions occurring particularly in aspirin-sensitive patients. It was notable for its potent analgesic effects comparable to opioids for some pain types.

Yes, Zomepirac is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL19490. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5733. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Zomepirac di PillFYI

Struktur

Data Cepat

Rumus: C15H14ClNO3

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.